Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2003

01-06-2003

Spouse controls in family case-control studies: a methodological consideration

Authors: Bas A. J. Verhage, Katja K. H. Aben, Huub Straatman, André L. M. Verbeek, Terri H. Beaty, Lambertus A. Kiemeney

Published in: Familial Cancer | Issue 2/2003

Login to get access
Metadata
Title
Spouse controls in family case-control studies: a methodological consideration
Authors
Bas A. J. Verhage
Katja K. H. Aben
Huub Straatman
André L. M. Verbeek
Terri H. Beaty
Lambertus A. Kiemeney
Publication date
01-06-2003
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2003
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1023/A:1025737025219

Other articles of this Issue 2/2003

Familial Cancer 2/2003 Go to the issue

OriginalPaper

Bannayan–Riley–Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases

Erratum

Erratum

Abstract List

Abstracts presented at the XVIth symposium of The Netherlands Foundation for the Detection of Hereditary Tumours, 'New Developments in Hereditary Cancer', 31 January 2003, Utrecht, The Netherlands

Letter to the Editor

Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population

ReviewPaper

Familial melanoma: a complex disorder leading to controversy on DNA testing

Letter to the Editor

The information and support needs of women at high risk of familial breast and ovarian cancer: how can cancer genetic services give patients what they want?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits